CVE-2023-40153

Cross-site Scripting in DEXMA DEXGate

Description

The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software.

Category

5.4
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.26%
Third-Party Advisory cisa.gov
Affected: DEXMA DexGate
Published at:
Updated at:

References

Link Tags
https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02 third party advisory us government resource

Frequently Asked Questions

What is the severity of CVE-2023-40153?
CVE-2023-40153 has been scored as a medium severity vulnerability.
How to fix CVE-2023-40153?
To fix CVE-2023-40153, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-40153 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-40153 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-40153?
CVE-2023-40153 affects DEXMA DexGate.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.